The neurotropic coronavirus JHM strain of mouse hepatitis virus persists in oligodendroglia despite the presence of virusspecific CD8 T cells. Expression of programmed death 1 (PD-1) and B7-H1 were studied during acute and persistent infection to examine whether this negative regulatory mechanism contributes to CNS viral persistence. The majority of CNS-infiltrating CD8 T cells expressed PD-1, with the highest levels on virus-specific CD8 T cells. Moreover, despite control of infectious virus, CD8 T cells within the CNS of persistently infected mice maintained high PD-1 expression. Analysis of virus-susceptible target cells in vivo revealed that B7-H1 expression was regulated in a cell type-dependent manner. Oligodendroglia and microglia up-regulated B7-H1 following infection; however, although B7-H1 expression on oligodendroglia was prominent and sustained, it was significantly reduced and transient on microglia S everal features of the CNS make it a challenging environment for the immune response to efficiently clear virus. These obstacles include the blood-brain barrier, a specialization of the vasculature in the CNS that limits leukocyte entry (1). In addition, the absence of classical lymphoid drainage and restricted Ag presentation by CNS resident cells hinders induction, recruitment, and retention of adaptive immune cells. Furthermore, in contrast to peripheral infections, several target cells of CNS infections are terminally differentiated, nonrenewable cells which have evolved mechanisms to avoid extensive immune-mediated damage. However, the same mechanisms protecting CNS resident cells from extensive immune-mediated pathology also favor establishment of viral persistence.A variety of inhibitory molecules and their ligands on T cells and infected cells contribute to T cell dysfunction, thereby fostering viral persistence. Among these are the programmed death 1 (PD-1) 5 receptor and its ligand B7-H1, also known as PD-L1, which belong to the B7:CD28 family (2). PD-1 is inducibly expressed on T cells, B cells (3), monocytes (4), and NK cells (5). B7-H1 is constitutively expressed on T cells, B cells, macrophages, and dendritic cells and is further up-regulated after stimulation (6, 7). B7-H1 is also expressed on a variety of nonhematopoietic cell types including vascular endothelial cells (8), epithelial cells (9), and cells of the nervous system (10 -13). PD-1:B7-H1 interactions trigger a noneffective T cell response, referred to as "T cell exhaustion," which is characterized by impaired proliferation, cytolysis, and cytokine production (8, 9, 14 -24). Exhausted T cells were initially described in chronic lymphocytic choriomeningitis virus-infected mice (24) and similar dysfunction of T cells has been reported during HIV (19, hepatitis C virus (15,26,27)-, and simian immunodeficiency virus (28)-persistent infections. Similar to pathogens exploiting the PD-1:B7-H1 pathway to establish persistence, expression of B7-H1 on tumors may also serve as an immune evasion strategy (29,30).The role of inhibitory mol...